1. Home
  2. TRVI vs PCT Comparison

TRVI vs PCT Comparison

Compare TRVI & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

N/A

Current Price

$11.86

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

N/A

Current Price

$5.70

Market Cap

1.6B

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
TRVI
PCT
Founded
2011
2015
Country
United States
United States
Employees
N/A
157
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TRVI
PCT
Price
$11.86
$5.70
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$20.38
$13.00
AVG Volume (30 Days)
1.2M
4.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1,185.70
Revenue Next Year
N/A
$49.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.85
$5.40
52 Week High
$14.39
$17.37

Technical Indicators

Market Signals
Indicator
TRVI
PCT
Relative Strength Index (RSI) 51.73 27.34
Support Level $10.04 N/A
Resistance Level $12.11 $9.56
Average True Range (ATR) 0.70 0.58
MACD 0.17 -0.24
Stochastic Oscillator 53.89 0.13

Price Performance

Historical Comparison
TRVI
PCT

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: